| [1] |
Sethi S, Quint PS, O′Seaghdha CM, et al. C4 Glomerulopathy: a disease entity associated with C4d deposition [J]. Am J Kidney Dis, 2016, 67(6): 949-953.
|
| [2] |
Smith RJH, Appel GB, Blom AM, et al. C3 glomerulopathy-understanding a rare complement-driven renal disease [J]. Nat Rev Nephrol, 2019, 15(3): 129-143.
|
| [3] |
Levey AS, Eckardt KU, Dorman NM, et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference [J]. Kidney Int, 2020, 97(6): 1117-1129.
|
| [4] |
Sethi S, Nasr SH, De Vriese AS, et al. C4d as a diagnostic tool in proliferative GN [J]. J Am Soc Nephrol, 2015, 26(11): 2852-2859.
|
| [5] |
Allam M, Fathy H, Abd Allah D, et al. Lupus nephritis: correlation of immunohistochemical expression of C4d, CD163-positive M2c-like macrophages and Foxp3-expressing regulatory T cells with disease activity and chronicity [J]. Lupus, 2020, 29(8): 943-953.
|
| [6] |
Sato Y, Sasaki S, Okamoto T, et al. Mesangial C4d deposition at diagnosis in childhood immunoglobulin A nephropathy [J]. Pediatr Int, 2019, 61(11): 1133-1139.
|
| [7] |
Nam KH, Joo YS, Lee C, et al. Predictive value of mesangial C3 and C4d deposition in IgA nephropathy [J]. Clin Immunol, 2020, 211: 108331.
|
| [8] |
Ali A, Schlanger L, Nasr SH, et al. Proliferative C4 dense deposit disease, acute thrombotic microangiopathy, a monoclonal gammopathy, and acute kidney failure [J]. Am J Kidney Dis, 2016, 67(3): 479-482.
|